Here we go again. With Aduhelm largely sidelined, Biogen and Eisai are hoping for a better fortunes with their next Alzheimer's disease therapy lecanemab, which is now fully filed with the FDA.

Biogen has announced it will give up ownership and halt sales of Aduhelm, an embattled Alzheimer's disease drug that was scrutinized following its 2021 approval. Biogen said it terminated a ...

After months of debate about the validity of its phase 3 clinical trials for Alzheimer's therapy Aduhelm, Biogen has published the results in a peer-review journal, allowing physicians to look at ...

Eli Lilly is releasing single-dose vials of weight loss drug Zepbound that will help adults living with obesity. Zepbound 2.5 ...

This form of Zepbound is sold as a vial that needs to be given by a syringe, although patients can still do it themselves. Zepbound and Mounjaro are both brand names for tirzepatide. However ...

Vials are small glass or plastic bottles used for storage. Depending on supplier they can be supplied in amber or clear glass, plastic, with or without markings and in various configurations of ...

This investigative series explores the science, money and politics behind the approval of the Alzheimer’s drug aducanumab. Read to learn more about this controversial drug and its implications ...

Vaccine vials have to be able to withstand significant stress The pharmaceutical company worker stood at the top of a stairwell, holding a tiny glass vial in their hand. They held the vial out ...

For a 4-week supply of the weekly injections, the discount at LillyDirect translates to $399 for a 2.5-mg single-dose vial ($99.75 per vial) and $549 for the 5-mg dose ($137.25 per vial), which ...

To sign up for Becker's Pharmacy Report E-Newsletter or any of our other E-Newsletters, click here. If you are experiencing difficulty receiving our newsletters, you may need to whitelist our new ...

Donanemab was approved as a 300 mg/20 mL single-dose vial in patients with a confirmed ... Biogen’s decision to discontinue aducanumab (Aduhelm), effective November 2024. 10 The FDA granted ...